BackAdamas Pharmaceuticals Overview

Adamas Pharmaceuticals Cost of Revenue

Cost of Revenue analysis for ADMS.

Quarterly Cost of Revenue

$576000.00
↑ 18.03% YoY

As of Sep 30, 2021

Annual Cost of Revenue (TTM)

$2.08M
↑ 10.73% YoY

Trailing 12 months ending Sep 30, 2021

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin